ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 38 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,261,000 | -31.5% | 2,740,000 | 0.0% | 0.01% | -38.5% |
| Q2 2020 | $16,440,000 | -20.3% | 2,740,000 | 0.0% | 0.01% | -40.9% |
| Q1 2020 | $20,632,000 | -45.2% | 2,740,000 | 0.0% | 0.02% | -38.9% |
| Q4 2019 | $37,675,000 | +242.8% | 2,740,000 | +196.2% | 0.04% | +200.0% |
| Q3 2019 | $10,989,000 | -15.1% | 925,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $12,941,000 | -21.8% | 925,000 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $16,539,000 | +13.7% | 925,000 | 0.0% | 0.02% | -5.3% |
| Q4 2018 | $14,550,000 | – | 925,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |